Episurf Medical received its first Notice of Allowance from The Canadian Intellectual Property Office, entitled “Surgical kit for cartilage repair comprising implant and a set of tools,” with a focus on the company’s Episealer® Femoral Twin implant and its design, commonly applied in cases of elongated cartilage lesions.
Episealer technology pairs an implant with a proprietary set of surgical instruments and a damage marking report for surgical pre-planning.
Further, the company was granted an additional patent in Australia, entitled “Method and node for manufacturing a surgical kit for cartilage repair.” This addresses Episurf’s 3D-based assessment of joint lesions.
Episurf Medical received its first Notice of Allowance from The Canadian Intellectual Property Office, entitled “Surgical kit for cartilage repair comprising implant and a set of tools,” with a focus on the company’s Episealer® Femoral Twin implant and its design, commonly applied in cases of elongated cartilage lesions.
Episealer technology...
Episurf Medical received its first Notice of Allowance from The Canadian Intellectual Property Office, entitled “Surgical kit for cartilage repair comprising implant and a set of tools,” with a focus on the company’s Episealer® Femoral Twin implant and its design, commonly applied in cases of elongated cartilage lesions.
Episealer technology pairs an implant with a proprietary set of surgical instruments and a damage marking report for surgical pre-planning.
Further, the company was granted an additional patent in Australia, entitled “Method and node for manufacturing a surgical kit for cartilage repair.” This addresses Episurf’s 3D-based assessment of joint lesions.
Copy to clipboard 
